Coastline Trust Co purchased a new position in Tekla Healthcare Investors (NYSE:HQH) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 10,329 shares of the financial services provider’s stock, valued at approximately $239,000.

A number of other institutional investors have also bought and sold shares of HQH. Stifel Financial Corp grew its position in Tekla Healthcare Investors by 108.3% in the first quarter. Stifel Financial Corp now owns 22,327 shares of the financial services provider’s stock worth $474,000 after buying an additional 11,606 shares during the last quarter. Citadel Advisors LLC grew its position in Tekla Healthcare Investors by 44.7% in the first quarter. Citadel Advisors LLC now owns 16,927 shares of the financial services provider’s stock worth $364,000 after buying an additional 5,229 shares during the last quarter. UBS Group AG grew its position in Tekla Healthcare Investors by 2.8% in the first quarter. UBS Group AG now owns 345,693 shares of the financial services provider’s stock worth $7,443,000 after buying an additional 9,520 shares during the last quarter. LPL Financial LLC grew its position in Tekla Healthcare Investors by 28.2% in the first quarter. LPL Financial LLC now owns 47,560 shares of the financial services provider’s stock worth $1,024,000 after buying an additional 10,457 shares during the last quarter. Finally, Janney Montgomery Scott LLC grew its position in Tekla Healthcare Investors by 3.2% in the second quarter. Janney Montgomery Scott LLC now owns 134,635 shares of the financial services provider’s stock worth $2,895,000 after buying an additional 4,112 shares during the last quarter. Hedge funds and other institutional investors own 19.83% of the company’s stock.

In other news, President Daniel R. Omstead acquired 3,882 shares of the stock in a transaction on Wednesday, October 17th. The shares were purchased at an average cost of $21.78 per share, for a total transaction of $84,549.96. Following the transaction, the president now owns 73,606 shares in the company, valued at approximately $1,603,138.68. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.00% of the company’s stock.

Tekla Healthcare Investors stock opened at $21.47 on Friday. Tekla Healthcare Investors has a 1 year low of $20.36 and a 1 year high of $25.17.

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 28th. Shareholders of record on Tuesday, August 28th were given a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a yield of 8.76%. The ex-dividend date of this dividend was Monday, August 27th.

Tekla Healthcare Investors Company Profile

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.

Recommended Story: Dow Jones Industrial Average (DJIA)

Institutional Ownership by Quarter for Tekla Healthcare Investors (NYSE:HQH)

Receive News & Ratings for Tekla Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tekla Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.